RhumbLine Advisers’s Nuvectis Pharma NVCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $94.7K | Buy |
+12,678
| New | +$94.7K | ﹤0.01% | 3547 |
|
|
2024
Q3 | – | Sell |
-1,871
| Closed | -$11.8K | – | 4289 |
|
|
2024
Q2 | $11.8K | Sell |
1,871
-5,631
| -75% | -$35.6K | ﹤0.01% | 3959 |
|
|
2024
Q1 | $61.5K | Buy |
7,502
+229
| +3% | +$1.88K | ﹤0.01% | 3578 |
|
|
2023
Q4 | $60.7K | Hold |
7,273
| – | – | ﹤0.01% | 3581 |
|
|
2023
Q3 | $93.7K | Buy |
7,273
+495
| +7% | +$6.38K | ﹤0.01% | 3485 |
|
|
2023
Q2 | $108K | Buy |
+6,778
| New | +$108K | ﹤0.01% | 3498 |
|